{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:05:01Z","timestamp":1780081501765,"version":"3.54.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013415","name":"Purdue University Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA023168"],"award-info":[{"award-number":["P30CA023168"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK044533-20"],"award-info":[{"award-number":["DK044533-20"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cyto.2018.08.012","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T19:06:42Z","timestamp":1534532802000},"page":"154518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"124","author":[{"given":"Saravana Kumar Kailasam","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Andrisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8256","key":"10.1016\/j.cyto.2018.08.012_b0005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"10003","key":"10.1016\/j.cyto.2018.08.012_b0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2018.08.012_b0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480C","author":"Seeger","year":"2015","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.cyto.2018.08.012_b0020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2018.08.012_b0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.antiviral.2017.11.015","article-title":"The diverse functions of the hepatitis B core\/capsid protein (HBc) in the viral life cycle: implications for the development of HBc-targeting antivirals","volume":"149","author":"Diab","year":"2018","journal-title":"Antiviral Res."},{"issue":"40","key":"10.1016\/j.cyto.2018.08.012_b0030","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses","volume":"111","author":"Koniger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/v9050125","article-title":"A role for the host DNA damage response in hepatitis B virus cccDNA formation-and beyond?","volume":"9","author":"Schreiner","year":"2017","journal-title":"Viruses"},{"issue":"8219","key":"10.1016\/j.cyto.2018.08.012_b0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(81)92877-4","article-title":"Survival of hepatitis B virus after drying and storage for one week","volume":"1","author":"Bond","year":"1981","journal-title":"Lancet"},{"issue":"RR-16","key":"10.1016\/j.cyto.2018.08.012_b0045","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.012_b0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/aem.32.4.572-574.1976","article-title":"Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages","volume":"32","author":"Petersen","year":"1976","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.012_b0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/147.2.185","article-title":"Postnatal infectivity of hepatitis B surface antigen-carrier mothers","volume":"147","author":"Beasley","year":"1983","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.012_b0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/146.2.198","article-title":"Incidence of hepatitis B virus infections in preschool children in Taiwan","volume":"146","author":"Beasley","year":"1982","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.012_b0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.aje.a114698","article-title":"Detection of hepatitis B virus DNA in asymptomatic hepatitis B surface antigen carriers: relation to sexual transmission","volume":"126","author":"Tassopoulos","year":"1987","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.012_b0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890220102","article-title":"Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal)","volume":"22","author":"Coursaget","year":"1987","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0080","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/infdis\/163.5.1138","article-title":"The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state","volume":"163","author":"Bodsworth","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.012_b0085","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.1985.03350360066020","article-title":"Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization","volume":"253","author":"Stevens","year":"1985","journal-title":"Jama"},{"key":"10.1016\/j.cyto.2018.08.012_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrgastro.2011.33","article-title":"Hepatitis B therapy","volume":"8","author":"Kwon","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2018.08.012_b0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coviro.2018.04.006","article-title":"Perspectives and limitations for nucleo(t)side analogs in future HBV therapies","volume":"30","author":"Levrero","year":"2018","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.012_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2017.04.012","article-title":"Current treatment guidelines of chronic hepatitis B: the role of nucleos(t)ide analogues and peginterferon","volume":"31","author":"Ghany","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","article-title":"Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma","volume":"46","author":"Lin","year":"2007","journal-title":"J. Hepatol."},{"issue":"25","key":"10.1016\/j.cyto.2018.08.012_b0110","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.cyto.2018.08.012_b0115","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"Association for the study of liver, AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cyto.2018.08.012_b0125","article-title":"Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance","volume":"3","author":"Yang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"issue":"17","key":"10.1016\/j.cyto.2018.08.012_b0130","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"15","key":"10.1016\/j.cyto.2018.08.012_b0135","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","article-title":"Control of hepatitis B virus replication by innate response of HepaRG cells","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cyto.2018.08.012_b0145","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/v2071394","article-title":"Innate antiviral immune responses to hepatitis B virus","volume":"2","author":"Ait-Goughoulte","year":"2010","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.cyto.2018.08.012_b0150","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jhep.2015.07.014","article-title":"Early inhibition of hepatocyte innate responses by hepatitis B virus","volume":"63","author":"Luangsay","year":"2015","journal-title":"J. Hepatol."},{"issue":"1 Suppl","key":"10.1016\/j.cyto.2018.08.012_b0155","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.08.012_b0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.cyto.2018.08.012_b0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cytogfr.2007.06.021","article-title":"STAT dynamics","volume":"18","author":"Reich","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biochi.2010.02.009","article-title":"STAT1 and pathogens, not a friendly relationship","volume":"92","author":"Najjar","year":"2010","journal-title":"Biochimie"},{"issue":"49","key":"10.1016\/j.cyto.2018.08.012_b0175","doi-asserted-by":"crossref","first-page":"47572","DOI":"10.1074\/jbc.M207536200","article-title":"SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei","volume":"277","author":"Wu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.cyto.2018.08.012_b0180","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1128\/MCB.22.16.5662-5668.2002","article-title":"Identification of a nuclear Stat1 protein tyrosine phosphatase","volume":"22","author":"ten Hoeve","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.012_b0185","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1073\/pnas.86.4.1203","article-title":"Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells","volume":"86","author":"Dale","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"10","key":"10.1016\/j.cyto.2018.08.012_b0190","first-page":"3550","article-title":"A transcriptional enhancer and an interferon-responsive sequence in major histocompatibility complex class I genes","volume":"6","author":"Vogel","year":"1986","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0195","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.85.1.252","article-title":"Hepatitis B virus suppresses expression of human beta-interferon","volume":"85","author":"Twu","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9","key":"10.1016\/j.cyto.2018.08.012_b0200","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/jvi.65.9.4699-4704.1991","article-title":"Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene","volume":"65","author":"Whitten","year":"1991","journal-title":"J. Virol."},{"issue":"Pt 8","key":"10.1016\/j.cyto.2018.08.012_b0205","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1099\/vir.0.18966-0","article-title":"Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore\/core proteins","volume":"84","author":"Fernandez","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"Pt 12","key":"10.1016\/j.cyto.2018.08.012_b0210","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1099\/vir.0.82959-0","article-title":"Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1","volume":"88","author":"Wu","year":"2007","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JVI.01292-06","article-title":"Inhibition of alpha interferon signaling by hepatitis B virus","volume":"81","author":"Christen","year":"2007","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.012_b0220","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.02.057","article-title":"Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice","volume":"140","author":"Lutgehetmann","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cyto.2018.08.012_b0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0230","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(01)00269-0","article-title":"Arginine methylation of STAT1 modulates IFNalpha\/beta-induced transcription","volume":"104","author":"Mowen","year":"2001","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.cyto.2018.08.012_b0235","doi-asserted-by":"crossref","first-page":"15342","DOI":"10.1128\/JVI.79.24.15342-15350.2005","article-title":"Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1","volume":"79","author":"Duong","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.gastro.2003.10.076","article-title":"Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A","volume":"126","author":"Duong","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cyto.2018.08.012_b0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.antiviral.2009.10.011","article-title":"Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha","volume":"85","author":"Li","year":"2010","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0250","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B","volume":"66","author":"Lebosse","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.012_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.06.042","article-title":"Methyltransferase SETD2-mediated methylation of STAT1 Is critical for interferon antiviral activity","volume":"170","author":"Chen","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-017-0003-0","article-title":"Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA","volume":"19","author":"Liu","year":"2018","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.012_b0265","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat. Immunol."},{"issue":"Pt 8","key":"10.1016\/j.cyto.2018.08.012_b0270","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","volume":"91","author":"Yu","year":"2010","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ccr.2013.11.011","article-title":"Hepatic RIG-I predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma","volume":"25","author":"Hou","year":"2014","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.cyto.2018.08.012_b0285","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/JVI.02280-09","article-title":"Hepatitis B virus replication induces methylation of both host and viral DNA","volume":"84","author":"Vivekanandan","year":"2010","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.cyto.2018.08.012_b0290","doi-asserted-by":"crossref","first-page":"20217","DOI":"10.1074\/jbc.M111.231068","article-title":"Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2","volume":"286","author":"Testoni","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cyto.2018.08.012_b0295","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"6176","key":"10.1016\/j.cyto.2018.08.012_b0300","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cyto.2018.08.012_b0305","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.dnarep.2014.03.030","article-title":"Base excision repair: a critical player in many games","volume":"19","author":"Wallace","year":"2014","journal-title":"DNA Repair (Amst.)"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0310","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1038\/s41598-017-13082-z","article-title":"IFN-alpha-mediated base excision repair pathway correlates with antiviral response against Hepatitis B virus infection","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2018.08.012_b0320","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.21187","article-title":"Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication","volume":"43","author":"Bonvin","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0325","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1038\/s41598-018-23525-w","article-title":"Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes","volume":"8","author":"Lucifora","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0330","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/35073080","article-title":"A weak signal for strong responses: interferon-alpha\/beta revisited","volume":"2","author":"Taniguchi","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0335","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev.Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0340","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx133","article-title":"Relapse-free survival as a surrogate for overall survival in the evaluation of stage II-III melanoma adjuvant therapy","volume":"110","author":"Suciu","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0345","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hpb.2017.01.012","article-title":"Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up","volume":"19","author":"Ohman","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.cyto.2018.08.012_b0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2016.06.033","article-title":"A site-selective hyaluronan-interferonalpha2a conjugate for the treatment of ovarian cancer","volume":"236","author":"Montagner","year":"2016","journal-title":"J. Controll. Release: Off. J. Controll. Release Soc."},{"issue":"36","key":"10.1016\/j.cyto.2018.08.012_b0355","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4254\/wjh.v9.i36.1296","article-title":"Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"9","author":"Kamiyama","year":"2017","journal-title":"World J Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.29156","article-title":"Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma","volume":"66","author":"Yang","year":"2017","journal-title":"Hepatology"},{"issue":"44","key":"10.1016\/j.cyto.2018.08.012_b0365","doi-asserted-by":"crossref","first-page":"16448","DOI":"10.1073\/pnas.0607830103","article-title":"RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins","volume":"103","author":"Xiao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"11","key":"10.1016\/j.cyto.2018.08.012_b0370","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1158\/0008-5472.CAN-14-2928","article-title":"PLK1 and HOTAIR accelerate proteasomal degradation of SUZ12 and ZNF198 during hepatitis B virus-induced liver carcinogenesis","volume":"75","author":"Zhang","year":"2015","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.012_b0375","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.28698","article-title":"RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2\/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis","volume":"64","author":"Zhang","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cyto.2018.08.012_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/genes9030137","article-title":"Hepatitis B virus-associated hepatocellular carcinoma and hepatic cancer stem cells","volume":"9","author":"Mani","year":"2018","journal-title":"Genes (Basel)"},{"issue":"7330","key":"10.1016\/j.cyto.2018.08.012_b0385","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cyto.2018.08.012_b0390","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2016.05.022","article-title":"EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes","volume":"65","author":"Mani","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.012_b0395","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer\u2013new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0400","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.celrep.2014.05.045","article-title":"EZH2-mediated inactivation of IFN-gamma-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer","volume":"8","author":"Wee","year":"2014","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.012_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.012_b0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.celrep.2017.06.036","article-title":"Identification of a druggable pathway controlling glioblastoma invasiveness","volume":"20","author":"Pencheva","year":"2017","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.cyto.2018.08.012_b0415","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncb3533","article-title":"Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis","volume":"19","author":"Celia-Terrassa","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.012_b0420","doi-asserted-by":"crossref","first-page":"E498","DOI":"10.1073\/pnas.1715118115","article-title":"Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma","volume":"115","author":"Lu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cyto.2018.08.012_b0425","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-17-0675","article-title":"Disruption of IFN-I signaling promotes HER2\/Neu tumor progression and breast cancer stem cells","author":"Castiello","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.012_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.11.018","article-title":"Intrinsic immunity shapes viral resistance of stem cells","volume":"172","author":"Wu","year":"2018","journal-title":"Cell"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661830348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661830348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:53:55Z","timestamp":1760907235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346661830348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":86,"alternative-id":["S104346661830348X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.08.012","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154518"}}